Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa

Intensive Care Medicine

Volumn 36, Issue 7, 2010, Pages 1147-1155

  Lu, Qin ^a   Girardi, Cassio ^a,f   Zhang, Mao ^a,g   Bouhemad, Belaïd ^a   Louchahi, Kamel ^b   Petitjean, Olivier ^b   Wallet, Frédéric ^c   Becquemin, Marie Helene ^d   Le Naour, Gilles ^d   Marquette, Charles Hugo ^e   Rouby, Jean Jacques ^a,d  

^a SORBONNE UNIVERSITÉ   (France)

^b AVICENNE HOSPITAL   (France)

^c INSERM   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITÉ CÔTE D'AZUR   (France)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^g ZHEJIANG UNIVERSITY   (China)

Author keywords

Antibiotic; Colistin; Mechanical ventilation; Nebulization; Pneumonia; Pseudomonas aeruginosa

Indexed keywords

COLISTIMETHATE; ANTIINFECTIVE AGENT; COLISTIN;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; ARTICLE; AUTOPSY; BACTERIAL COUNT; BRONCHUS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; INOCULATION; LUNG BURDEN; LUNG DEPOSIT; LUNG PARENCHYMA; LUNG VENTILATION; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NEBULIZATION; NONHUMAN; PIGLET; PSEUDOMONAS INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; ANIMAL; DISEASE MODEL; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; NEBULIZER; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SWINE;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-BACTERIAL AGENTS; COLISTIN; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; INJECTIONS, INTRAVENOUS; NEBULIZERS AND VAPORIZERS; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SWINE;

EID: 77954387227     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-1879-4     Document Type: Article

References (41)

1. JJ Rouby 1996 Nosocomial infection in the critically ill: the lung as a target organ Anesthesiology 84 757 759 10.1097/00000542-199604000-00001 1:STN:280:DyaK283hs1ahsA%3D%3D 8638828
2. JL Vincent DJ Bihari PM Suter HA Bruining J White MH Nicolas-Chanoin M Wolff RC Spencer M Hemmer 1995 The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee JAMA 274 639 644 10.1001/jama.274.8.639 1:STN:280:DyaK2MzmsVWnuw%3D%3D 7637145
3. J Rello D Mariscal F March P Jubert F Sanchez J Valles P Coll 1998 Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am J Respir Crit Care Med 157 912 916 1:STN:280: DyaK1c7ns1Orug%3D%3D 9517611
4. S Crouch Brewer RG Wunderink CB Jones KV Leeper Jr 1996 Ventilator-associated pneumonia due to Pseudomonas aeruginosa Chest 109 1019 1029 10.1378/chest.109.4.1019 1:STN:280:DyaK283htFGqtQ%3D%3D 8635325
5. N Mesaros P Nordmann P Plesiat M Roussel-Delvallez J Van Eldere Y Glupczynski Y Van Laethem F Jacobs P Lebecque A Malfroot, et al. 2007 Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium Clin Microbiol Infect 13 560 578 10.1111/j.1469-0691.2007.01681.x 1:CAS:528:DC%2BD2sXms1Oksbs%3D 17266725
6. J Li RL Nation JD Turnidge RW Milne K Coulthard CR Rayner DL Paterson 2006 Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections Lancet Infect Dis 6 589 601 10.1016/S1473-3099(06)70580-1 1:CAS:528:DC%2BD28XpvVOrurg%3D 16931410
7. ME Falagas SK Kasiakou 2005 Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections Clin Infect Dis 40 1333 1341 10.1086/429323 1:CAS:528:DC%2BD2MXktlajsro%3D 15825037
8. ME Evans DJ Feola RP Rapp 1999 Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria Ann Pharmacother 33 960 967 10.1345/aph.18426 1:CAS:528:DyaK1MXmtlCgs7Y%3D 10492501
9. E Wolinsky JD Hines 1962 Neurotoxic and nephrotoxic effects of clolistin in patients with renal disease N Engl J Med 266 759 762 1:STN:280: DyaF387pvF2rsw%3D%3D 14008070
10. CM Elwood GD Lucas RC Muehrcke 1966 Acute renal failure associated with sodium colistimethate treatment Arch Intern Med 118 326 334 10.1001/archinte. 118.4.326 1:STN:280:DyaF2s%2Fks1CisQ%3D%3D 5925230
11. H Kallel L Hergafi M Bahloul A Hakim H Dammak H Chelly CB Hamida A Chaari N Rekik M Bouaziz 2007 Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study Intensive Care Med 33 1162 1167 10.1007/s00134-007-0675-2 1:CAS:528:DC%2BD1cXhtV2ltr%2FK 17530220
12. J Garnacho-Montero C Ortiz-Leyba FJ Jimenez-Jimenez AE Barrero-Almodovar JL Garcia-Garmendia IM Bernabeu-Wittel SL Gallego-Lara J Madrazo-Osuna 2003 Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP Clin Infect Dis 36 1111 1118 10.1086/374337 1:CAS:528:DC%2BD3sXksFSgtLY%3D 12715304
13. CA Fica JI Cespedes GM Gompertz VM Jalon ZA Sakurada LE Saez 2007 Intravenous colistin in the treatment of infections due to pan-resistant Gram negative bacilli Rev Chilena Infectol 24 360 367
14. ME Falagas PI Rafailidis SK Kasiakou P Hatzopoulou A Michalopoulos 2006 Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections Clin Microbiol Infect 12 1227 1230 10.1111/j.1469-0691.2006.01559.x 1:CAS:528:DC%2BD2sXktlCqug%3D%3D 17121631
15. A Poudyal BP Howden JM Bell W Gao RJ Owen JD Turnidge RL Nation J Li 2008 In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae J Antimicrob Chemother 62 1311 1318 10.1093/jac/dkn425 1:CAS:528:DC%2BD1cXhtl2gs7%2FE 18922815
16. D Plachouras M Karvanen LE Friberg E Papadomichelakis A Antoniadou I Tsangaris I Karaiskos G Poulakou F Kontopidou A Armaganidis, et al. 2009 Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria Antimicrob Agents Chemother 53 3430 3436 10.1128/AAC.01361-08 1:CAS:528:DC%2BD1MXps1ygsrw%3D 19433570
17. Rouby JJ, Goldstein I, Lu Q (2006) Inhaled antibiotic therapy. In: Tobin MJ (ed) Principles and practice of mechanical ventilation, Chapter 64, 2nd edn. McGraw-Hill, New York, pp 1311-1332
18. M Tonnellier F Ferrari I Goldstein A Sartorius CH Marquette JJ Rouby 2005 Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen Anesthesiology 102 995 1000 10.1097/00000542-200505000-00019 1:CAS:528:DC%2BD2MXjsFKgt7w%3D 15851887
19. I Goldstein F Wallet A Nicolas-Robin F Ferrari CH Marquette JJ Rouby 2002 Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets Am J Respir Crit Care Med 166 1375 1381 10.1164/rccm.200204-363OC 12406838
20. F Ferrari Q Lu C Girardi O Petitjean CH Marquette F Wallet JJ Rouby 2009 Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa Intensive Care Med 35 1792 1800 10.1007/s00134-009-1605-2 1:CAS:528:DC%2BD1MXhtFOiu7fF 19652947
21. A Michalopoulos SK Kasiakou Z Mastora K Rellos AM Kapaskelis ME Falagas 2005 Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis Crit Care 9 R53 R59 10.1186/cc3020 15693967
22. AL Kwa C Loh JG Low A Kurup VH Tam 2005 Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa Clin Infect Dis 41 754 757 10.1086/432583 16080101
23. F Ratjen E Rietschel D Kasel R Schwiertz K Starke H Beier S van Koningsbruggen H Grasemann 2006 Pharmacokinetics of inhaled colistin in patients with cystic fibrosis J Antimicrob Chemother 57 306 311 10.1093/jac/dki461 1:CAS:528:DC%2BD28XovVGmsg%3D%3D 16396919
24. I Goldstein F Wallet J Robert MH Becquemin CH Marquette JJ Rouby 2002 Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs Am J Respir Crit Care Med 165 171 175 11790649
25. F Ferrari ZH Liu Q Lu MH Becquemin K Louchahi G Aymard CH Marquette JJ Rouby 2008 Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers Intensive Care Med 34 1718 1723 10.1007/s00134-008-1126-4 18542922
26. PP Le Brun AI de Graaf AA Vinks 2000 High-performance liquid chromatographic method for the determination of colistin in serum Ther Drug Monit 22 589 593 10.1097/00007691-200010000-00014 1:CAS:528:DC%2BD3cXnt1Kmtro%3D 11034265
27. CH Marquette D Wermert F Wallet MC Copin AB Tonnel 1999 Characterization of an animal model of ventilator-acquired pneumonia Chest 115 200 209 10.1378/chest.115.1.200 1:STN:280:DyaK1M7it1CksQ%3D%3D 9925085
28. A Sartorius Q Lu S Vieira M Tonnellier G Lenaour I Goldstein JJ Rouby 2007 Mechanical ventilation and lung infection in the genesis of air-space enlargement Crit Care 11 R14 10.1186/cc5680 17274806
29. R Reina E Estenssoro G Saenz HS Canales R Gonzalvo G Vidal G Martins A Das Neves O Santander C Ramos 2005 Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study Intensive Care Med 31 1058 1065 10.1007/s00134-005-2691-4 15983759
30. BW Gunderson KH Ibrahim LB Hovde TL Fromm MD Reed JC Rotschafer 2003 Synergistic activity of colistin and ceftazidime against multiantibiotic- resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model Antimicrob Agents Chemother 47 905 909 10.1128/AAC.47.3.905-909.2003 12604520
31. J Li K Coulthard R Milne RL Nation S Conway D Peckham C Etherington J Turnidge 2003 Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis J Antimicrob Chemother 52 987 992 10.1093/jac/dkg468 1:CAS:528:DC%2BD3sXpvVelsrY%3D 14585859
32. N Aoki K Tateda Y Kikuchi S Kimura C Miyazaki Y Ishii Y Tanabe F Gejyo K Yamaguchi 2009 Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa J Antimicrob Chemother 63 534 542 10.1093/jac/dkn530 1:CAS:528:DC%2BD1MXitVSitLw%3D 19147523
33. DE Nix SD Goodwin CA Peloquin DL Rotella JJ Schentag 1991 Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response Antimicrob Agents Chemother 35 1953 1959 1:CAS:528:DyaK3MXmt1alsrY%3D 1759813
34. N Markou SL Markantonis E Dimitrakis D Panidis E Boutzouka S Karatzas P Rafailidis H Apostolakos G Baltopoulos 2008 Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study Clin Ther 30 143 151 10.1016/j.clinthera.2008.01. 015 1:CAS:528:DC%2BD1cXhtVWlt7fJ 18343250
35. Ryan G, Mukhopadhyay S, Singh M (2000) Nebulised anti-pseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst Rev CD001021
36. AP MacGowan R Wise 2001 Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests J Antimicrob Chemother 48 suppl 1 17 28 1:CAS:528:DC%2BD3MXlsVegtrw%3D 11420334
37. M Elman I Goldstein CH Marquette F Wallet G Lenaour JJ Rouby 2002 Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia Anesthesiology 97 199 206 10.1097/00000542-200207000-00028 1:CAS:528: DC%2BD38XlslSqur8%3D 12131123
38. MP Barrowcliffe JG Jones 1987 Solute permeability of the alveolar capillary barrier Thorax 42 1 10 10.1136/thx.42.1.1 1:STN:280: DyaL2s3pt1ygsw%3D%3D 3303423
39. JS Brody CA Vaccaro NS Hill S Rounds 1984 Binding of charged ferritin to alveolar wall components and charge selectivity of macromolecular transport in permeability pulmonary edema in rats Circ Res 55 155 167 1:CAS:528: DyaL2cXmt1OqtLw%3D 6430590
40. ME Falagas II Siempos PI Rafailidis IP Korbila E Ioannidou A Michalopoulos 2009 Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series Respir Med 103 707 713 10.1016/j.rmed.2008.11.018 19118994
41. A Michalopoulos D Fotakis S Virtzili C Vletsas S Raftopoulou Z Mastora ME Falagas 2008 Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study Respir Med 102 407 412 10.1016/j.rmed.2007.10.011 18060758